On March 7, 2019, MDC Group Joint Stock Company officially signed a strategic cooperation agreement with a leading technology and pharmaceutical partner in Incheon city (South Korea). According to the cooperation content, MDC takes on the role of the lead unit in researching, developing, and deploying a specialized Deep Learning and Data Mining System, directly integrated into the research and production process of pharmaceuticals and cosmetics.
The system built by MDC is designed to solve two in-depth technological problems: analyzing raw material formula data and monitoring production lines. The Data Mining platform allows synthesizing and analyzing millions of datasets on active ingredient properties, ingredient stability, and clinical feedback from consumers. Based on that, Deep Learning algorithms will analyze and predict complex interactions between compounds, proposing optimal formulation ratios. The solution significantly shortens new product research time, optimizes operating costs, and increases accuracy in quality control.
The successful implementation of the project in Incheon - a leading pharmaceutical and cosmetic industrial center in Asia - not only affirms MDC's capability to develop complex Artificial Intelligence and Big Data solutions but also marks an important step forward in the group's technology export strategy and international market expansion.